Introduction: Angiotensin II is an octapeptide (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) widely used as a reference compound in laboratory research on peptide-receptor interactions. This overview covers its structure, synthesis, and in vitro study applications only.

Structure and Synthesis: Angiotensin II is produced by solid-phase peptide synthesis, purified by preparative reversed-phase HPLC, and confirmed by mass spectrometry. Purity is assessed by analytical HPLC, and net peptide content is determined before use in quantitative laboratory assays so that experimental concentrations are based on verified material.

In Vitro Study Applications:

• Cell culture models examining peptide binding and signaling readouts under controlled laboratory conditions
• Receptor pharmacology experiments comparing analogue structures in vitro
• Assay development and validation using a well-characterized reference peptide
• Stability and degradation studies in buffer and culture media conditions

Analytical Notes: Researchers typically confirm identity by mass spectrometry, purity by RP-HPLC, and content by amino acid analysis or quantitative methods before use, since compound quality directly affects reproducibility across experiments.

References: Published laboratory literature on angiotensin peptides in experimental models; standard peptide synthesis and characterization literature.

Disclaimer: This article is for laboratory research education only. All products referenced are not for human consumption / research use only. No medical, therapeutic, dosing, or efficacy information is provided or implied.